Suppr超能文献

[肺结核患者血清腺苷脱氨酶及其同工酶活性与淋巴细胞亚群的关系]

[Relationship between the activity of serum adenosine deaminase including its isozymes and lymphocyte subpopulation in patients with pulmonary tuberculosis].

作者信息

Ishii S, Nagasawa H, Tai H, Noda Y, Akiyama K, Takeda H, Okajima N, Okano H

机构信息

Department of Internal Medicine (Daisan Hospital II), Jikei University School of Medicine, Tokyo, Japan.

出版信息

Kekkaku. 1997 Mar;72(3):153-9.

PMID:9103825
Abstract

Adenosine deaminase (ADA) is one of the enzymes in the purine metabolism and divided into two isozymes, ADA-1 and ADA-2. It is known that the activity of this enzyme is elevated in the sera of patients with pulmonary tuberculosis, sarcoidosis and other diseases, however there are few reports about the change of the activity of this enzyme under treatment. It is often said that this enzyme may have its origin in T lymphocyte, but it remains to be proved. That goes for each of two isozymes, too. In this study, we investigated the activity of serum total ADA, ADA-1 and ADA-2 in patients with pulmonary tuberculosis on admission and after three months' treatment. We also studied the correlation of lymphocyte subpopulation with these enzymes. The activity of total ADA, ADA-1 and ADA-2 was significantly higher in the sera of patients with pulmonary tuberculosis than in those of healthy persons. ADA-2 activity correlated significantly and negatively with the number of CD3+ lymphocytes and CD4+ lymphocytes. The change rate of ADA-2 activity during three months' treatment correlated significantly and negatively with the change rate of CD4/8. These results may suggest that there is a close correlation between the activity of ADA-2 and lymphocyte subpopulation in the sera of patients with pulmonary tuberculosis. ADA-1 activity did not correlate with lymphocyte subpopulation significantly, but it decreased significantly after three months' treatment. The activity of ADA-1 also may have certain relations with the disease process of pulmonary tuberculosis.

摘要

腺苷脱氨酶(ADA)是嘌呤代谢中的一种酶,分为两种同工酶,即ADA - 1和ADA - 2。已知该酶的活性在肺结核、结节病和其他疾病患者的血清中会升高,然而关于该酶活性在治疗过程中的变化报道较少。人们常说这种酶可能起源于T淋巴细胞,但仍有待证实。两种同工酶的情况也是如此。在本研究中,我们调查了肺结核患者入院时及治疗三个月后的血清总ADA、ADA - 1和ADA - 2的活性。我们还研究了淋巴细胞亚群与这些酶的相关性。肺结核患者血清中总ADA、ADA - 1和ADA - 2的活性显著高于健康人。ADA - 2活性与CD3 +淋巴细胞和CD4 +淋巴细胞的数量显著负相关。治疗三个月期间ADA - 2活性的变化率与CD4/8的变化率显著负相关。这些结果可能表明,肺结核患者血清中ADA - 2活性与淋巴细胞亚群之间存在密切相关性。ADA - 1活性与淋巴细胞亚群无显著相关性,但治疗三个月后显著降低。ADA - 1的活性也可能与肺结核的病程有一定关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验